Healthcare marketing in Saudi Arabia operates under the Ministry of Health's medical advertising framework, which sets specific rules for what can be communicated, how claims must be substantiated, and which approvals are required before publication. This piece walks through the operational sequence Saudi healthcare marketers should follow to publish compliantly in 2026.
Step 1: Identify whether the content requires MoH pre-approval
MoH advertising rules apply to medical service advertising — direct promotion of treatments, procedures, or specific medical outcomes. Patient education content (general health information without practice promotion) sits in a softer regulatory zone but should still meet accuracy standards. Internal communications and recruitment content fall outside the medical advertising framework.
Step 2: Confirm all claims are substantiated
Every claim about clinical outcome, treatment effectiveness, or comparative advantage must be supported by documented evidence: peer-reviewed clinical research, manufacturer-approved efficacy data, or the practice's own anonymised outcomes data. Unsubstantiated claims (even widely-accepted ones in the medical community) require formal documentation before publication.
Step 3: Display the required practice credentials
Medical advertising must display: the MoH practice licence number, the principal physician's medical licence number, and the Saudi Commission for Health Specialties (SCFHS) registration where applicable. These appear in the content footer or a dedicated credentials section.
Step 4: Apply the comparative-advertising restrictions
Direct comparison with named competitors is restricted. Comparative language ("the best clinic in Riyadh", "more effective than other treatments") requires either specific substantiation or removal. Practices typically replace comparative framing with capability framing ("specialised in...", "experienced with...").
Step 5: Handle patient testimonials within the framework
Patient testimonials are permitted with explicit informed consent and accurate representation. Testimonials must not imply guaranteed outcomes, must not include unsubstantiated medical claims, and require renewable consent if used for more than 12 months.
Step 6: Submit for pre-approval when required
Specific content types require MoH pre-approval before publication: paid television and radio advertising, large outdoor advertising, and certain digital paid advertising depending on platform and claim specifics. Submission turnaround: 10–21 working days for standard submissions.
Step 7: Maintain the compliance record
For every published piece of advertising content, the practice should retain: substantiation documentation for each claim, MoH approval reference where applicable, signed patient consent forms for any testimonials, and the published version archive. Retention period: minimum 24 months from last publication.
Common compliance failures
- Unsubstantiated outcome claims ("guaranteed results", specific success rates without documentation)
- Missing or outdated licence display
- Comparative language without substantiation
- Patient testimonials without dated consent
- Content recycled across markets without re-checking against current Saudi MoH rules
What this means for marketing programmes
Healthcare marketing agencies operating in Saudi Arabia should treat MoH compliance as a foundational layer, not a final review step. Compliance review at content concept stage, script stage, and pre-publication stage typically catches issues that final-review-only workflows miss. The cost of late-stage compliance issues (re-shooting video content, re-designing materials, retracting published content) significantly exceeds the cost of layered review.
For more on healthcare marketing operations, see the framework articles on the Knowledge Hub. For compliance-reviewed healthcare marketing services, see our healthcare marketing services.
